Illumina Discovery Symposium at AACR 2014

17 April 2014

With the 2014 American Association for Cancer Research annual meeting in San Diego, Illumina hosted a pre-conference Discovery Symposium focusing on advances being made in understanding and monitoring cancer made possible through next-generation sequencing technologies. A stellar lineup of eight researchers presented their latest findings and discussed their experiences with bringing NGS into their labs.

Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.